Urohealth to acquire gynaecology specialist Imagyn
This article was originally published in Clinica
Urohealth Systems will take over Imagyn Medical in a stock deal which values Imagyn at about $70 million. The deal will add micro-invasive systems to diagnose and treat gynaecological and reproductive disorders to Urohealth's products in urology and general surgery.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.